Infectious Disease Advisor news story
Real-world data show PrEP users have high uptake of doxycycline post-exposure prophylaxis (DoxyPEP) for bacterial sexually transmitted infections (STIs), resulting in a lower STI positivity rate, according to study results published in Sexually Transmitted Infections.
Starting in November 2022, the San Francisco AIDS Foundation Sexual Health Clinic (Magnet) started offering DoxyPEP to all PrEP users. This retrospective cohort analysis was a planned study of STI positivity after the DoxyPEP policy implementation.
Continued evaluation of uptake, adherence, impact on STI incidence and antimicrobial resistance will be essential as DoxyPEP use expands.
Read the full news story here.
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
Source : Infectious Disease Advisor
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.